Europe Electrophysiology Devices Market Introduction and Overview
According to SPER Market Research, the Europe Electrophysiology Devices Market is estimated to reach USD 6.02 billion by 2033 with a CAGR 10.26%.
The report includes an in-depth analysis of the Europe Electrophysiology Devices Market, including market size and trends, product mix, distribution channels, and supplier analysis. Heart and other organ electrical irregularities are diagnosed and treated with specialist medical equipment called electrophysiology devices. These tools are mostly used in cardiology to monitor electrical activity in the heart, detect arrhythmias, and direct operations such as catheter ablation. Tools including mapping systems that visualize electrical signals, ablation devices that administer energy to eliminate aberrant tissue producing irregular heart rhythms, and electrophysiology catheters that measure electrical signals by inserting them into the heart through blood veins are commonly included. In neurology, electrophysiological devices are also used to monitor and modify brain electrical activity in order to diagnose and treat diseases such as epilepsy.
- Acutus Medical received CE Mark for its AcQBlate FORCE ablation catheter and the Qubic Force Sensing Module (Qubic Force), and in December 2020, the AcQBlate Force Sensing Ablation System was introduced in Europe.
- Farapulse's FARAPULSE Pulsed Field Ablation (PFA) technology, which treats paroxysmal atrial fibrillation (AF), was granted the CE Mark in January 2021.
Market Opportunities and Challenges
Opportunities: The rising incidence of target diseases, developments in electrophysiology technology, and rising demand for catheter ablation operations are some of the reasons propelling the market's expansion. More than 6 million cardiovascular disease (CVD) cases were diagnosed in the European Union in 2019, and over 11 million CVD cases were reported throughout Europe annually, according to data from the European Society of Cardiology. Furthermore, each year in Europe, CVDs cause almost 3.9 million deaths. The growing incidence of cardiovascular disorders is anticipated to propel the market over the forecast period, as electrophysiological devices are widely used in the detection of heart failure rates.
Challenges: However, only a small percentage of cardiologists specialize in electrophysiology, according to the European Union of Medical Specialists. In Europe, the electrophysiological workforce is very stable, notwithstanding the unfavorable ratio. However, there is a noticeable lag in the geographical dispersion of EPs due to the lack of mobility among the bulk of established electrophysiologists. This has caused a gap between supply and demand as well as observable disparities among electrophysiologists. Therefore, a significant barrier to the expansion of the European electrophysiology business is the shortage of qualified electrophysiologists.
Market Competitive Landscape
The electrophysiology market in Europe is competitive, but not very so. A small number of the main firms presently control the majority of the market in terms of market share. Several companies have a significant market share in the European electrophysiology market, including Abbott Laboratories, Boston Scientific Corporation, Biotronik, SE and Co. KG, GE Company (GE Healthcare), Microport Scientific Corporation, and Medtronic plc.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Product, By Disease |
| Regions covered | Eastern region, Western region, Southern region, Northern region. |
| Companies Covered | Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, EP Solutions SA, GE Company (GE Healthcare), Johnson & Johnson, Koninklijke Philips N.V., Medtronic PLC, Microport Scientific Corporation, and Osypka Medical GmbH. |
COVID-19 Impact on Europe Electrophysiology Devices Market
The market for electrophysiology (EP) devices in Europe was greatly affected by the COVID-19 epidemic, both in terms of supply and demand. However, as things have improved, the market has begun to rebound. The European healthcare system had to deal with a number of issues during the pandemic's peak, such as overburdened hospital systems, postponed or cancelled non-urgent surgeries, and a change in focus to virus management. The market development temporarily slowed as a result of the postponement of elective treatments, such as those using electrophysiology equipment for diagnosing and treating arrhythmias.
Key Target Audience:
- Hospitals and Healthcare Providers
- Cardiologists and Electrophysiologists
- Medical Device Manufacturers
- Research and Academic Institutions
- Patients with Cardiac Arrhythmias
- Government and Regulatory Bodies
- Insurance Companies and Payers
Our in-depth analysis of the Europe Electrophysiology Devices Market includes the following segments:
| By Product: | Ablation CathetersLaboratery DevicesDiagnostics CathetersAccess DevicesOthers |
| By Disease: | Atrial FibrillationAtrial FlutterWolff-Parkinson-White SyndromeAtrioventricular Nodal Reentry TachycardiaOthers |
Key Topics Covered in the Report:
- Europe Electrophysiology Devices Market Size (FY’2024-FY’2033)
- Overview of Europe Electrophysiology Devices Market
- Segmentation of Europe Electrophysiology Devices Market By Product (Ablation Catheters, Laboratery Devices, Diagnostics Catheters, Access Devices, Others)
- Segmentation of Europe Electrophysiology Devices Market By Disease (Atrial Fibrillation, Atrial Flutter, Wolff-Parkinson-White Syndrome, Atrioventricular Nodal Reentry Tachycardia, Others)
- Expansion Analysis of Europe Electrophysiology Devices Market
- Problems and Obstacles in Europe Electrophysiology Devices Market
- Competitive Landscape in the Europe Electrophysiology Devices Market
- Impact of COVID-19 and Demonetization on Europe Electrophysiology Devices Market
- Details on Current Investment in Europe Electrophysiology Devices Market
- Competitive Analysis of Europe Electrophysiology Devices Market
- Prominent Players in the Europe Electrophysiology Devices Market
- SWOT Analysis of Europe Electrophysiology Devices Market
- Europe Electrophysiology Devices Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe Electrophysiology Devices Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe Electrophysiology Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Electrophysiology Devices Market
7. Europe Electrophysiology Devices Market, By Product (USD Million) 2020-2033
7.1. Europe Electrophysiology Devices Market Size, Share and Forecast, By Product, 2020-2026
7.2. Europe Electrophysiology Devices Market Size, Share and Forecast, By Product, 2027-2033
7.3. Ablation Catheters
7.4. Laboratery Devices
7.5. Diagnostics Catheters
7.6. Access Devices
7.7. Others
8. Europe Electrophysiology Devices Market, By Disease (USD Million) 2020-2033
8.1. Europe Electrophysiology Devices Market Size, Share and Forecast, By Disease, 2020-2026
8.2. Europe Electrophysiology Devices Market Size, Share and Forecast, By Disease, 2027-2033
8.3. Atrial Fibrillation
8.4. Atrial Flutter
8.5. Wolff-Parkinson-White Syndrome
8.6. Atrioventricular Nodal Reentry Tachycardia
8.7. Others
9. Europe Electrophysiology Devices Market Forecast, 2020-2033 (USD Million)
9.1. Europe Electrophysiology Devices Market Size and Market Share
10. Europe Electrophysiology Devices Market, By Region, 2020-2033 (USD Million)
10.1. Europe Electrophysiology Devices Market Size and Market Share By Region (2020-2026)
10.2. Europe Electrophysiology Devices Market Size and Market Share By Region (2027-2033)
10.3. France
10.4. Germany
10.5. Italy
10.6. Spain
10.7. United Kingdom
10.8. Rest of Europe
11. Company Profile
11.1. Abbott Laboratories
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Biotronik SE & Co. KG
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. Boston Scientific Corporation
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. EP Solutions SA
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. GE Company (GE Healthcare)
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Johnson & Johnson
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. Koninklijke Philips N.V.
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Medtronic PLC
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Microport Scientific Corporation
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Osypka Medical GmbH
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Others
12. Conclusion
13. Reference Links
14. List of Abbreviations
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
